CAREDX, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CAREDX, INC. (CDNA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $400.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-25
- CAREDX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $400.00K.
- CAREDX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$10.60M, a 124.42% decline from fiscal 2023.
- CAREDX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $43.40M, a 212.23% increase from fiscal 2022.
- CAREDX, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $13.90M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $400.00K 10-K · filed 2026-02-25 | |
| 2024-12-31 | -$10.60M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $43.40M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $13.90M 10-K · filed 2024-02-28 | |
| 2021-12-31 | -$27.20M 10-K · filed 2023-02-27 | |
| 2020-12-31 | $8.40M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $4.10M 10-K · filed 2021-02-24 | |
| 2018-12-31 | -$5.40M 10-K · filed 2020-02-28 | $5.40M 10-K · filed 2019-03-06 |
| 2017-12-31 | -$21.40M 10-K · filed 2019-03-06 | |
| 2016-12-31 | $6.20M 10-K · filed 2018-03-22 | |
| 2015-12-31 | $3.70M 10-K · filed 2017-04-21 | |
| 2014-12-31 | -$1.90M 10-K · filed 2016-03-29 | |
| 2013-12-31 | -$500.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |